Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

0
Player Avatar Boa1952 (30.91) Submitted: 7/2/2012 8:17:51 PM : Outperform Start Price: $10.05 ARNA Score: -42.92

Can you "Buy Out"?

Featured Broker Partners


Advertisement